Cargando…
Regulatory landscape and clinical implication of MBD3 in human malignant glioma
In this article we inspect the roles and functions of the methyl-CpG-binding domain protein 3 (MBD3) in human malignant glioma, to assess its potential as an epigenetic biomarker for prognosis. The regulatory effects of MBD3 on glioma transcriptome were first profiled by high-throughput microarray....
Autores principales: | Cui, Yi, Li, Jian, Weng, Ling, Wirbisky, Sara E., Freeman, Jennifer L., Liu, Jingping, Liu, Qing, Yuan, Xianrui, Irudayaraj, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340251/ https://www.ncbi.nlm.nih.gov/pubmed/27835581 http://dx.doi.org/10.18632/oncotarget.13173 |
Ejemplares similares
-
Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy
por: Cui, Yi, et al.
Publicado: (2015) -
Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma
por: Choudhury, Samrat Roy, et al.
Publicado: (2015) -
MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2
por: Li, Jian, et al.
Publicado: (2021) -
Atrazine Exposure and Reproductive Dysfunction through the Hypothalamus-Pituitary-Gonadal (HPG) Axis
por: Wirbisky, Sara E., et al.
Publicado: (2015) -
MBD2 and MBD3: elusive functions and mechanisms
por: Menafra, Roberta, et al.
Publicado: (2014)